New test developed to detect men at high risk of prostate cancer recurrence
Vienna, Austria: A new genetic “signature” to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday).
CanCertainty for All: Cancer’s Not Fair, But Accessing Treatment Should Be
Toronto, ON – March 10, 2014 – There is no disputing a cancer diagnosis is among the worst news a person or their family could receive. But there is another harsh reality for many patients in Ontario and Atlantic Canada who face uncertainty and financial hardship as a result of discrimination when it comes to accessing effective cancer treatments that are taken orally. An unprecedented unification of more than 30 Canadian patient groups, physicians and health care charities, led by Kidney Cancer Canada, are working together to ensure all Canadian cancer patients have CanCertainty (www.CanCertaintyForAll.ca) – certainty that if cancer strikes them or a loved one they will have fair and equal access to the treatment they need, whether intravenous (IV) or oral.
Support for Those Affected by Prostate Cancer
Toronto, ON - January 28, 2014 – We are pleased to announce a partnership between Prostate Cancer Canada and the Canadian Cancer Society in launching the Prostate Cancer Information Service (PCIS), which provides support to anyone affected by prostate cancer. Available in a number of languages, these confidential and evidence-based services include a phone line, email response, resources and referrals to prostate cancer support programs.
Stanfield’s partners with Prostate Cancer Canada Atlantic Region
Halifax, Nova Scotia, January 17, 2014 –– Prostate Cancer Canada Atlantic Region is pleased to announce that Stanfield’s is the presenting sponsor for the inaugural Pants Off For Prostate Cancer. “Pants Off” is an upscale dance with no pants taking place, Saturday, February 22nd at 8 pm at the World Trade & Convention Centre in Halifax in support of Prostate Cancer Canada Atlantic Region.
Prostate Cancer Canada Releases New Recommendations
TORONTO: New recommendations released today by Prostate Cancer Canada (PCC) will empower Canadian males to take a more active role in monitoring their number one cancer risk: prostate cancer. A recent nationwide poll showed that while 87% of Canadian men aged 35+ fear prostate cancer, less than half anticipate being tested in the next 12 months – even though early diagnosis can increase the odds of survival.
Igniting the Discovery Spark through Movember research funding
Toronto, ON – July 17, 2013 – Prostate Cancer Canada is dedicated to supporting prostate cancer researchers on the verge of an early-stage research breakthrough with the Movember Discovery Grants program. This program allows both junior investigators at the start of their research career and more established investigators to pursue new important directions in prostate cancer research. Each recipient of the Movember Discovery Grant will receive up to $200,000 in funding over a two-year term.